Published • loading... • Updated
Cadila Pharmaceuticals and Wellesta Holdings Singapore Sign Strategic Joint Venture to Accelerate Growth Across South-East Asia and Emerging International Markets
Summary by PNI
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Cadila Pharmaceuticals and Wellesta Holdings Singapore Sign Strategic Joint Venture to Accelerate Growth Across South-East Asia and Emerging International Markets
Ahmedabad – Cadila Pharmaceuticals, one of India’s leading integrated pharmaceutical companies, and Wellesta Holdings Pte. Ltd., Singapore, have signed a Memorandum of Understanding (MoU) to establish a strategic Joint Venture aimed at expanding access to high-quality healthcare solutions across South-East Asia and selected international markets. The partnership brings together the complementary strengths of both organizations. Cadila Pharmaceu…
4th of July SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
